Item 2.02 Results of Operations and Financial Condition.
On August 13, 2020, we issued a press release announcing our financial results
for the first quarter ended June 30, 2020. A copy of the press release is
attached hereto as Exhibit 99.1. The information in this Item 2.02 and the
attached Exhibit 99.1 are being furnished and shall not be deemed "filed" for
the purposes of Section 18 of the Securities and Exchange Act of 1934, as
amended, or otherwise subject to the liabilities of that Section. The
information in this Item 2.02 and the attached exhibit shall not be incorporated
by reference into any registration statement or other document pursuant to the
Securities Act of 1933, as amended
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Description
99.1 Press release issued by Regulus Therapeutics Inc. on August 13, 2020
relating to financial results
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses